Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Ticker SymbolELMD
Company nameElectromed Inc
IPO dateAug 13, 2010
CEOMr. James L. (Jim) Cunniff
Number of employees174
Security typeOrdinary Share
Fiscal year-endAug 13
Address500 Sixth Avenue Nw
CityNEW PRAGUE
Stock exchangeNYSE American Consolidated
CountryUnited States of America
Postal code56071
Phone19527589299
Websitehttps://smartvest.com/
Ticker SymbolELMD
IPO dateAug 13, 2010
CEOMr. James L. (Jim) Cunniff
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data